Mahamaya Lifesciences Limited (BOM:544611)
India
· Delayed Price · Currency is INR 160.55
-8.45 (-5.00%)
At close: Mar 9, 2026
Mahamaya Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Net Income | 139.34 | 128.12 | 53.76 | 37.51 | 27.23 |
| Depreciation & Amortization | 16.15 | 12.92 | 9.62 | 8.46 | 8.22 |
| Other Amortization | 5.18 | 5.18 | 4.45 | 4.26 | 1.37 |
| Loss (Gain) From Sale of Assets | -0.28 | -0.28 | -0.18 | -0.21 | - |
| Other Operating Activities | 124.37 | 91.42 | 65.05 | 37 | 16.54 |
| Change in Accounts Receivable | -307.81 | -201.54 | -187.81 | -4.22 | -26.95 |
| Change in Inventory | -502.62 | -491.84 | -162.46 | -161.46 | -59.25 |
| Change in Accounts Payable | 372 | 324.1 | -44.06 | 105.02 | 90.03 |
| Change in Other Net Operating Assets | 69.96 | 98.86 | 27.02 | -15.12 | -35.58 |
| Operating Cash Flow | -83.69 | -33.05 | -234.6 | 11.24 | 21.62 |
| Operating Cash Flow Growth | - | - | - | -47.99% | - |
| Capital Expenditures | -45.31 | -50.44 | -15.13 | -28.94 | -32.69 |
| Sale of Property, Plant & Equipment | 1.16 | 3.66 | 0.5 | 0.4 | - |
| Other Investing Activities | 1.26 | 2.03 | 0.84 | 0.03 | 0.15 |
| Investing Cash Flow | -42.89 | -44.75 | -13.79 | -28.51 | -32.53 |
| Short-Term Debt Issued | - | 113.29 | 322.93 | - | - |
| Long-Term Debt Issued | - | - | 6.39 | 2,277 | 79.95 |
| Total Debt Issued | 230.82 | 113.29 | 329.32 | 2,277 | 79.95 |
| Short-Term Debt Repaid | - | -59.17 | -2.91 | - | - |
| Long-Term Debt Repaid | - | -20.03 | -23.91 | -2,225 | -49.91 |
| Total Debt Repaid | -31.55 | -79.2 | -26.82 | -2,225 | -49.91 |
| Net Debt Issued (Repaid) | 199.28 | 34.09 | 302.5 | 52.07 | 30.04 |
| Issuance of Common Stock | - | 137.94 | - | - | - |
| Other Financing Activities | -90.7 | -87.36 | -57.23 | -28.52 | -16.27 |
| Financing Cash Flow | 108.58 | 84.67 | 245.27 | 23.55 | 13.77 |
| Miscellaneous Cash Flow Adjustments | -0 | - | 0 | - | - |
| Net Cash Flow | -18.01 | 6.86 | -3.12 | 6.28 | 2.86 |
| Free Cash Flow | -129 | -83.49 | -249.73 | -17.7 | -11.07 |
| Free Cash Flow Margin | -4.59% | -3.16% | -15.46% | -1.29% | -1.23% |
| Free Cash Flow Per Share | -7.26 | -4.92 | -18.18 | -1.29 | -0.81 |
| Cash Interest Paid | 71.12 | 68.08 | 57.23 | 28.52 | 16.27 |
| Cash Income Tax Paid | - | 18.6 | 11.86 | 10.56 | 12.07 |
| Levered Free Cash Flow | - | -130.13 | -305.05 | -39.34 | - |
| Unlevered Free Cash Flow | - | -95.68 | -276.27 | -22.89 | - |
| Change in Working Capital | -368.46 | -270.42 | -367.31 | -75.78 | -31.74 |
Source: S&P Capital IQ. Standard template. Financial Sources.